August 29, 2024
6 min read
Putting the ‘Patient’ Back in Patient Services
Putting the patient back in patient services means we do more, go deeper, and customize offerings.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Interview
January 15, 2026
8 min read
Interview with Josh Hardman of Psychedelic Alpha
UBC talked with Josh Hardman, founder of Psychedelic Alpha, to discuss the evolving landscape of psychedelic drug development—from shifting regulatory expectations to the role of psychotherapy and the impact of stigma on patient access. Hardman shares a clear-eyed perspective on where the field stands today, the scientific rigor needed to advance it, and what he’s watching most closely as the industry moves toward potential first approvals.
Blog
January 12, 2026
7 min read
Navigating 2026: Patient service themes, challenges, and solutions
As we look ahead to 2026, patient access and support services face growing complexity—from affordability challenges and evolving care models to the rise of specialty therapies. This blog explores the key trends shaping the healthcare landscape and offers strategic solutions, including AI-powered innovation, digital transformation, and partnerships that drive better outcomes. Discover how UBC is leading the way with patient-first strategies to simplify the patient and product journey.
Blog
December 16, 2025
18 min read
Navigating the AI Landscape: Choosing the Right Model for Your PV Needs
AI is no longer just a buzzword—it’s a practical tool shaping how we work every day. Learn how UBC leverages AI models to streamline tasks, enhance decision-making, and maintain compliance.
Posts by Date
Blog
Blog
August 26, 2024
6 min read
EMA/HMA Revised Guidance on Risk Minimization Measures
UBC is the leading provider of evidence development solutions with expertise in uniting evidence and access.
Blog
August 16, 2024
4 min read
The Importance of Patient Choice
Providing the patient with choice throughout their journey empowers them to take an active role in therapy initiation and persistence.
Blog
August 5, 2024
6 min read
Navigating Launch Readiness with FDA Negotiations
REMS readiness is a key component for certain drugs launch plans - are you on top of approval timelines and milestones and IT build needs?
Blog
July 29, 2024
5 min read
ICH/FDA Draft Guidance on RWD Safety Studies Highlight Their Increased Importance
Understand the latest international opinion on the plan, design, and analysis of pharmacoepidemiological safety studies using RWD.
Blog
July 22, 2024
9 min read
Enhance Your Pharmacovigilance and Regulatory Compliance with Expert PV System Transition Management and Seamless Migration
Whether your transition includes a vendor change, acquisition, or portfolio expansion, UBC makes it easy to transition your system.
Blog
June 24, 2024
4 min read
RWD Enrichment Studies: Linking Pre- and Post-Trial Data Utilizing Tokenization
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
Blog
June 7, 2024
5 min read
Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs
The UBC PV Tableau Data Analytics Platform provides an all-in-one dashboard system for safety Key Performance Indicators (KPIs) analysis and compliance oversight.
Blog
May 30, 2024
1 min read
Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI
UBC and Seqster talked with Chilmark Research about the power of patient-mediated electronic medical record release.
Previous
